BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31412013)

  • 1. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review.
    Marra G; Gontero P; Walz JC; Sivaraman A; Tourinho-Barbosa R; Cathelineau X; Sanchez-Salas R
    World J Urol; 2019 Aug; 37(8):1517-1534. PubMed ID: 30710157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robot-assisted Radical Prostatectomy After Focal Therapy: Oncological, Functional Outcomes and Predictors of Recurrence.
    Marconi L; Stonier T; Tourinho-Barbosa R; Moore C; Ahmed HU; Cathelineau X; Emberton M; Sanchez-Salas R; Cathcart P
    Eur Urol; 2019 Jul; 76(1):27-30. PubMed ID: 30904357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy.
    Kimura M; Mouraviev V; Tsivian M; Mayes JM; Satoh T; Polascik TJ
    BJU Int; 2010 Jan; 105(2):191-201. PubMed ID: 19583717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
    Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
    J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
    van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
    Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer.
    von Hardenberg J; Cash H; Koch D; Borkowetz A; Bruendl J; Leyh-Bannurah SR; Kuru TH; Kowalewski KF; Schindele D; Mala KS; Westhoff N; Blana A; Schostak M;
    World J Urol; 2021 Oct; 39(10):3747-3754. PubMed ID: 33881557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
    Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
    BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
    Gontero P; Marra G; Alessio P; Filippini C; Oderda M; Munoz F; Linares E; Sanchez-Salas R; Challacombe B; Dasgupta P; Goonewardene S; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Piechaud T; Morlacco A; Vidit S; Rouprêt M; De La Taille A; Albisinni S; Gandaglia G; Mottrie A; Joshi S; Fiscus G; Berger A; Aron M; Van Der Poel H; Tilki D; Lawrentschuk N; Murphy DG; Leung G; Davis J; Karnes RJ;
    J Urol; 2019 Oct; 202(4):725-731. PubMed ID: 31075058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial.
    Reddy D; Shah TT; Dudderidge T; McCracken S; Arya M; Dobbs C; Emberton M; Fiorentino F; Day E; Prevost AT; Staffurth J; Sydes M; Winkler M; Ahmed HU
    Contemp Clin Trials; 2020 Jun; 93():105999. PubMed ID: 32302790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer.
    Chesnut GT; Tin AL; Sivaraman A; Takeda T; Lee T; Fainberg J; Benfante N; Sjoberg DD; Vargas HA; Fine SW; Scardino PT; Eastham JA; Coleman JA; Touijer KA; Zelefsky MJ; Ehdaie B
    Urol Oncol; 2021 Aug; 39(8):495.e17-495.e24. PubMed ID: 33583697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
    Gandaglia G; Briganti A; Clarke N; Karnes RJ; Graefen M; Ost P; Zietman AL; Roach M
    Eur Urol; 2017 Nov; 72(5):689-709. PubMed ID: 28189428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage high-intensity focused ultrasound for locally recurrent prostate cancer after low-dose-rate brachytherapy: oncological and functional outcomes.
    Hostiou T; Gelet A; Chapelon JY; Rouvière O; Mège-Lechevalier F; Lafon C; Tonoli-Catez H; Badet L; Crouzet S
    BJU Int; 2019 Nov; 124(5):746-757. PubMed ID: 31148367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
    van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR
    BJU Int; 2022 Nov; 130(5):611-618. PubMed ID: 35474600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.
    Bates AS; Ayers J; Kostakopoulos N; Lumsden T; Schoots IG; Willemse PM; Yuan Y; van den Bergh RCN; Grummet JP; van der Poel HG; Rouvière O; Moris L; Cumberbatch MG; Lardas M; Liew M; Van den Broeck T; Gandaglia G; Fossati N; Briers E; De Santis M; Fanti S; Gillessen S; Oprea-Lager DE; Ploussard G; Henry AM; Tilki D; van der Kwast TH; Wiegel T; N'Dow J; Mason MD; Cornford P; Mottet N; Lam TBL
    Eur Urol Oncol; 2021 Jun; 4(3):405-423. PubMed ID: 33423943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the risk-reward balance in focal therapy for prostate cancer-a contribution to the debate.
    Kluytmans A; Fütterer JJ; Emberton M; Sedelaar M; Grutters J
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):382-384. PubMed ID: 30664735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence after primary therapy for clinically localized prostate cancer: is radiation or surgery "Better" in the salvage setting?
    Wood CG
    J Surg Oncol; 2008 Apr; 97(5):376. PubMed ID: 18360819
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential treatment for recurrent localized prostate cancer.
    Van Der Poel HG; Moonen L; Horenblas S
    J Surg Oncol; 2008 Apr; 97(5):377-82. PubMed ID: 18360820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.
    Rosoff JS; Savage SJ; Prasad SM
    World J Urol; 2013 Dec; 31(6):1347-52. PubMed ID: 23358790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.